Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study [Phase 2]
A multicenter Phase 2 clinical trial evaluating an integrated induction-consolidation chemotherapy approach with transplantation for adult a…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Bleeding and Thrombotic Risk Prediction in Acute Leukemia: Clinical Utility of the Siriraj Acute Myeloid/Lymphoblastic Leukemia (SiAML) Score Versus Established Hemostatic Tools
This clinical trial aims to evaluate the clinical utility of the SiAML score versus established hemostatic tools for predicting bleeding and…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia [NA]
This entry notes a multicenter platform-type clinical study for refractory/recurrent acute myeloid leukemia in China, currently in the recru…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies [Phase 1]
A Phase 1 trial evaluating CD180 CAR-T therapy for relapsed or refractory CD180-positive hematologic malignancies is currently recruiting, i…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: ABO and Rh Blood Group Frequencies in Acute Leukemia Patients
A clinical trial conducted by Assiut University is investigating the frequencies of ABO and Rh blood groups in patients with acute leukemia …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial update comparing azacitidine plus venetoclax versus stem cell transplant in adults aged 65 and older with acute mye…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients [Phase 2]
Phase 2 clinical trial evaluating quizartinib in combination with chemotherapy for newly diagnosed pediatric FLT3-ITD+ and NPM1wt acute myel…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML Patients [Phase 3]
Open-label Phase 3 clinical trial CHIP-AML22/Master for newly diagnosed pediatric de novo acute myeloid leukemia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia [NA]
A clinical trial evaluating the combination of chidamide, venetoclax, and azacitidine for newly diagnosed acute myeloid leukemia is currentl…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer [Phase 1]
A Phase 1 study of PEP07, a Checkpoint Kinase 1 (CHK1) inhibitor, is currently recruiting in patients with acute myeloid leukemia and mantle…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation [Phase 1]
This document provides an update on a Phase 1 trial evaluating maintenance therapy with selinexor and azacitidine in patients with TP53-muta…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia
This item reports a completed clinical trial evaluating the impact of Optical Genome Mapping in acute myeloid leukemia.
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
This clinical trial investigates the use of allogeneic hematopoietic stem cell transplantation in newly diagnosed high-relapse-risk CEBPA-mu…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) [NA]
Clinical trial update for ACT evaluating compassionate communication and advance care planning to improve end-of-life care in hematologic di…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML [Phase 2]
Phase 2 clinical trial evaluating a Venetoclax-containing therapy with microtransplant for newly diagnosed acute myeloid leukemia is current…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia [NA]
This document provides a clinical trial update describing a novel transplantation approach for acute leukemia that combines ex vivo T-cell–d…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
This clinical trial update assesses the immune response to an RSV vaccine in patients with hematologic cancers, including multiple myeloma, …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia [NA]
This clinical trial compares specialty-delivered palliative care to oncology-delivered palliative care for adults with relapsed, primary ref…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT [Phase 2]
Phase 2 trial evaluating reduced ATG plus mini post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in haploidentical …
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction [Phase 3]
Phase 3 multicenter trial comparing a seven-day reduced venetoclax exposure with azacitidine to standard continuous venetoclax exposure with…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Observational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions
An observational clinical trial update on acute myeloid leukemia with an APL-like phenotype, focusing on distinct features and early vascula…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: The Risk of Acute Myeloid Leukaemia in Patients With Ewing's Sarcoma
This clinical trial update discusses the risk of developing acute myeloid leukemia in patients diagnosed with Ewing Sarcoma. The study statu…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]
BXCL701 is being studied in a Phase 1 trial for relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with excess blasts-2,…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options? [Phase 2]
Phase 2 clinical trial is evaluating repurposed itraconazole as an adjuvant therapy for acute myeloid leukemia; the study is not yet recruit…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics [Phase 3]
A Phase 3 trial comparing standard intensive chemotherapy with CPX-351 versus standard therapy alone in adults with newly diagnosed acute my…